Biomedical Engineering Reference
In-Depth Information
81. R. Gref, M. Luck, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R.H. Muller,
'Stealth' corona-core nanoparticles surface modifi ed by polyethylene glycol (PEG): Infl uences of the
corona (OEG chain length and surface density) and of the core composition on phagocytic uptake and
plasma protein adsorption, Colloidal and Surfaces B: Biointerfaces 18 (2000) 301-313.
82. M. Vittaz, D. Bazile, G. Spenlehauer, T. Verrecchia, M. Veillard, F. Puisieux, and D. Labarre, Effect
of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement
activators, Biomaterials 17 (1996) 1575 -1581.
83. D. Schrama, R.A. Reisfeld, and J.C. Becker, Antibody targeted drugs as cancer therapeutics, Nature
Reviews Drug Discovery 5 (2006) 147-159.
84. R. Bicknell, The realization of targeted antitumor therapy, British Journal of Cancer 92 (2005)
S2-S5.
85. Y. Cao and L. Lam, Bispecifi c antibody conjugates in therapeutics, Advanced Drug Delivery Reviews
55 (2003) 171-197.
86. G. Kohler and C. Milstein, Continuous cultures of fused cells secreting antibody of predefi ned specifi c-
ity, Nature 256 (1975) 495-497.
87. H. Li and Z.M. Qian, Transfferin/transferrin receptor-mediated drug delivery, Medicinal Research
Reviews 22 (2002) 225-250.
88. A. Widera, F. Norouziyan, and W.C. Shen, Mechanisms of TfR-mediated transcytosis and sorting in
epithelial cells and applications toward drug delivery, Advanced Drug Delivery Reviews 55 (2003)
1439 -1466.
89. Y. Lu and P.S. Low, Folate-mediated delivery of macromolecular anticancer therapeutic agents,
Advanced Drug Delivery Reviews 54 (2002) 675-693.
90. Y. Lu, E. Sega, C.P. Leamon, and P.S. Low, Folate receptor-targeted immunotherapy of cancer:
Mechanism and therapeutic potential, Advanced Drug Delivery Reviews 56 (2004) 1161-1176.
91. E.K. Park, S.B. Lee, and Y.M. Lee, Preparation and characterization of methoxy poly(ethylene glycol)/
poly( ε -caprolactone) amphiphilic block copolymeric nanospheres for tumor-specifi c folate-mediated
targeting of anticancer drugs, Biomaterials 26 (2005) 1053-1061.
92. E.K. Park, S.Y. Kim, S.B. Lee, and Y.M. Lee, Folate-conjugated methoxy poly(ethylene glycol)/
poly( ε -caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery, Jour-
nal of Controlled Release 109 (2005) 158-168.
93. S.H. Kim, J.H. Jeong, K.W. Chun, and T.G. Park, Target-specifi c cellular uptake of PLGA nanoparticles
coated with poly(l-lysine)-poly(ethylene glycol)-folate conjugate, Langmuir 21 (2005) 8852-8857.
94. R.J. Lee and P.S. Low, Delivery of liposomes into cultured KB cells via folate receptor-mediated endo-
cytosis, The Journal of Biological Chemistry 269 (1994) 3198-3204.
95. R.J. Lee and P.S. Low, Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro ,
Biochimica et Biophysica Acta 1233 (1995) 134-144.
96. Y. Luo, N.J. Bernshaw, Z.R. Lu, J. Kopecek, and G.D. Prestwich, Targeted delivery of doxorubicin by
HPMA copolymer-hyaluronan bioconjugates, Pharmaceutical Research 19 (2002) 396 - 402.
97. R.E. Eliaz and F.C. Szoka, Liposome-encapsulated doxorubicin targeted to CD44: A strategy to kill
CD44-overexpressing tumor cells, Cancer Research 61 (2001) 2592-2601.
98. M. Shadidi and M. Sioud, Selective targeting of cancer cells using synthetic peptides, Drug Resistance
Updates 6 (2003) 363-371.
99. J.D. Hood, M. Bednarski, R. Frausto, S. Guccione, R.A. Reisfeld, R. Xiang, and D.A. Cheresh, Tumor
regression by targeted gene delivery to the neovasculature, Science 296 (2002) 2404-2407.
100. E. Trachsel and D. Neri, Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell
transcytosis, Advanced Drug Delivery 58 (2006) 735-754.
101. S. Sengupta, D. Eavarone, I. Capila, G. Zhao, N. Watson, and T. Kiziltepe, Temporal targeting of tumor
cells and neovasculature with a nanoscale delivery system, Nature 436 (2005) 568-572.
102. H. Maeda, J. Fang, T. Inutsuka, and Y. Kitamoto, Vascular permeability enhancement in solid tumor:
Various factors, mechanisms involved and its implications, International Immunopharmacology 3 (2003)
319 -328.
103. G.M. Tozer, S.M. Ameer-Beg, J. Baker, P.R. Barber, S.A. Hill, R.J. Hodgkiss, R. Locke, V.E. Prize,
I. Wilson, and B. Vojnovic, Intravital imaging of tumour vascular networks using multi-photon
fl uorescence microscopy, Advanced Drug Delivery Review 57 (2005) 135-152.
104. H.S. Yoo, K.H. Lee, and J.E. Oh, In vitro and in vivo anti-tumor activities of nanoparticles based on
doxorubicin-PLGA conjugates, Journal of Controlled Release 68 (2000) 419-431.
Search WWH ::




Custom Search